leisure time -WSS

leisure time

author：knowledge 2025-09-27 17:03:02 - browse：6385

NIH headquarters — NIH research fellows want to unionize, in large part because they want a raise. Will that mean less money for grants? Lydia Polimeni/NIH

Several thousand research fellows at the National Institutes of Health want to unionize, in large part because they want to raise their pay stipends to something resembling a living wage near the agency headquarters in Bethesda, Md. But with a Congress that is looking on in suspicion at the NIH’s research and a debt ceiling deal that limits budget increases, where is the money going to come from?

Unlike private companies, federal agencies can’t always just give raises. This varies widely across the government, and from position to position. NIH trainees actually have it better than most, because they aren’t subject to the rigid federal pay scale that governs how much most people working in the administration can make. That doesn’t mean, however, that there’s always money for raises. It’s Congress, not the NIH itself, that sets the agency’s budget.

Finding money for raises, therefore, necessarily means taking money from somewhere else, said Richard Freeman, a professor of economics at Harvard.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Google says AlphaFold 3 can map a vast universe of biomolecules

Wikipedia

WSS

New England Journal of Medicine addresses racist history, slavery

Health and fitness trackers are measuring the wrong things

How I ended up pumping milk in a bathroom stall at JPM 2024

Risky weight loss products often used by teens globally, per study

Generative AI mines health records to identify patients’ social needs

Study: People of West African ancestry at greater risk of cardiac amyloidosis

entertainment

leisure time

focus

Wildfire smoke exposes gaps in outdoor worker protections

Doulas covered by Medicaid under New York's new plan

Duchenne breakthrough therapy leaves behind pioneering families

Medicare says breakthrough device reimbursement rule to come by summer

Novavax promises a turnaround & Lilly roils the obesity market

Readout LOUD podcast: brain research, obesity drug sales, Novartis

At least 13 dead in Texas as scorching temps continue

Telehealth startups turn to complex chronic diseases

Apple is now the first public company to be valued at $3 trillion

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

leisure time

Researchers on aging grapple with how to calculate biological age

Doulas covered by Medicaid under New York's new plan

Software glitch causes Tandem insulin pump to shutdown, FDA warns

Risky weight loss products often used by teens globally, per study

Shionogi licenses Pompe disease therapy from Maze Therapeutics

Readout Newsletter: Sanofi, Novavax, Maze x Shionogi news

focus

Wikipedia

hotspot

focus